GlassScriptPhysician profile
Khaled Meloud Sleik
NPI 1033221056
$2,607.62
in general payments reported to CMS, 2019-2025
22 companies · $637 in 2025
The $637 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $31.16 · 2021: $52.29 · 2022: $214 · 2023: $517 · 2024: $567 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,721.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $704.51 | 2019-2025 | Avvigo Guidance System, General - Therapies, Wolverine Coronary Cutting Balloon |
| Medtronic, INC. | $587.38 | 2022-2025 | Onyx Frontier, Symplicity G3, Ffrangio |
| Pfizer INC. | $179.73 | 2019 | |
| Abbott Laboratories | $161.04 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $153.26 | 2023-2024 | Optimizer, Optimizer |
| Abiomed | $135.86 | 2020-2024 | Impella |
| Shockwave Medical, INC | $121.34 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $85.12 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.49 | 2019-2023 | Lifevest |
| Canon Medical Systems USA, INC. | $67.51 | 2019 | |
| Atricure, INC. | $43.38 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Janssen Pharmaceuticals, INC | $42.96 | 2019 | |
| W. L. Gore & Associates, INC. | $42.90 | 2023-2025 | Gore Cardioform Septal Occluder |
| Heartflow, INC. | $39.00 | 2025 | |
| Astellas Pharma US INC | $34.92 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $25.52 | 2024 | Savvywire |
| Teleflex LLC | $23.46 | 2024 | Guideliner |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.29 | 2019 | |
| Biosense Webster, INC. | $22.42 | 2025 | Na |
| Cardiovascular Systems INC. | $17.37 | 2019 | |
| Amarin Pharma, INC. | $14.07 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaled Sleik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.